| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/12/2009 | US20090068145 Methods and Compositions Relating to Islet Cell Neogenesis |
| 03/12/2009 | US20090068144 Tetrahydro-isoquinolin-1-ones for the treatment of cancer |
| 03/12/2009 | US20090068142 Compositions and methods for treating coronavirus infection and sars |
| 03/12/2009 | US20090068141 Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
| 03/12/2009 | US20090068110 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | US20090068109 Anti-mcp-1 antibodies, compositions, methods and uses |
| 03/12/2009 | US20090068102 Treating stroke |
| 03/12/2009 | US20090068100 Cancerous disease modifying antibodies |
| 03/12/2009 | US20090068099 Cancerous disease modifying antibodies |
| 03/12/2009 | US20090068098 Antibodies and related molecules that bind to 58p1d12 proteins |
| 03/12/2009 | US20090068097 Method for non-invasive detection and treatment of cerebral aneurysms |
| 03/12/2009 | US20090068096 Sequence of stro-1 antibody variable region |
| 03/12/2009 | US20090068095 Carbonic anhydrase ix (g250) anitbodies and methods of use thereof |
| 03/12/2009 | US20090068094 Inhibitors of endo-exonuclease activity for treating cancer |
| 03/12/2009 | CA2698419A1 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 03/12/2009 | CA2698392A1 Thermal inactivation of rotavirus |
| 03/12/2009 | CA2698360A1 Compositions comprising yersinia pestis antigens |
| 03/12/2009 | CA2698343A1 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 03/12/2009 | CA2698301A1 Reduction of concomitant infections in pigs by the use of pcv2 antigen |
| 03/12/2009 | CA2698287A1 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | CA2698203A1 Humanized anti-cxcr5 antibodies, derivatives thereof and their use |
| 03/12/2009 | CA2698011A1 Porcine adeno-associated viruses |
| 03/12/2009 | CA2697930A1 Compound for controlling appetite |
| 03/12/2009 | CA2697922A1 Compositions that bind multiple epitopes of igf-1r |
| 03/12/2009 | CA2697612A1 Anti-igf-1r antibodies and uses thereof |
| 03/12/2009 | CA2697482A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 03/11/2009 | EP2034030A2 Novel compositions and methods for cancer |
| 03/11/2009 | EP2034023A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses |
| 03/11/2009 | EP2034015A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof |
| 03/11/2009 | EP2034012A1 Vaccine against viral rabbit hemorrhagic disease |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033659A2 Inhibitors of complement activation |
| 03/11/2009 | EP2033658A1 Anitbodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 03/11/2009 | EP2033657A1 Intraoperative trifunctional antibody application for prophylatic intraperitonal tumour cell dissemination |
| 03/11/2009 | EP2033655A1 Use of compounds that inhibit the EF-Tu-nucleolin interaction for preventing or treating tularemia |
| 03/11/2009 | EP2032701A1 Polynucleotides and polypeptide sequences involved in cancer |
| 03/11/2009 | EP2032603A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 03/11/2009 | EP2032169A2 Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap |
| 03/11/2009 | EP2032168A1 Capecitabine combination therapy |
| 03/11/2009 | EP2032167A2 A novel target in the treatment of cytokine release syndrome |
| 03/11/2009 | EP2032165A1 Bioactive purified hspe7 compositions |
| 03/11/2009 | EP2032164A1 Method for the preparation of specific antibodies against saccharidic antigens |
| 03/11/2009 | EP2032163A2 Adjuvant-sparing multi-dose influenza vaccination regimen |
| 03/11/2009 | EP2032162A2 Herv-k antigens, antibodies, and methods |
| 03/11/2009 | EP2032161A2 Vaccine |
| 03/11/2009 | EP2032160A2 Vaccine |
| 03/11/2009 | EP2032159A2 Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof |
| 03/11/2009 | EP2032158A2 Adjuvant compositions |
| 03/11/2009 | EP1904099B1 Thermoreversible immuno- adjuvant emulsion |
| 03/11/2009 | EP1737488B1 Treatment of fungal infections |
| 03/11/2009 | EP1699483B1 Combination vaccine for poultry |
| 03/11/2009 | EP1691824B1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 03/11/2009 | EP1468085B1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 03/11/2009 | EP1429845B1 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1355948B1 Materials and methods for treatment of hepatitis c |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1149162B1 Medicament for the treatment of c. pneumoniae infections |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384722A 疫苗组合物 Vaccine compositions |
| 03/11/2009 | CN101384714A Novel viral vector |
| 03/11/2009 | CN101384699A Method of producing rough strains of bacteria and uses thereof |
| 03/11/2009 | CN101384280A Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 03/11/2009 | CN101384279A Anti-amyloid immunogenic compositions, methods and uses |
| 03/11/2009 | CN101384278A 狂犬病疫苗 Rabies Vaccine |
| 03/11/2009 | CN101381776A Method for detecting PPN/MG61 expression and use thereof |
| 03/11/2009 | CN101381728A Human interferon alpha-2b recombinant bacillus calmette-guerin, construction method and identification method thereof |
| 03/11/2009 | CN101381681A Improved methods for producing oocysts |
| 03/11/2009 | CN101381402A NY-ESO-1 tumour antigen mimic epitope and use thereof |
| 03/11/2009 | CN101380472A Use of total saponin from Panax notoginseng stalks and leaves in preparing immunoadjuvants |
| 03/11/2009 | CN101380471A Preparation method of absorption diphtheria tetanus combined vaccine without formaldehyde and merthiolate |
| 03/11/2009 | CN101380470A Pig parvovirus live vaccine |
| 03/11/2009 | CN101380469A Production technique of turbot reddish body iridovirus inactivated vaccine |
| 03/11/2009 | CN101380468A Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof |
| 03/11/2009 | CN101380467A Multi-connection inactivated vaccine (antigen) liquid concentration technique |
| 03/11/2009 | CN101380466A Polypeptide vaccine for treating diseased induced by high pathogenic avian influenza virus H5N1 |
| 03/11/2009 | CN101380465A Construction method of Beta-alexin-2-tumor vaccine and uses thereof |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467598C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467597C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467591C Recombinant fowl influenza virus strain, its preparation method and the vaccine obtained therefrom |
| 03/11/2009 | CN100467083C Microprojection array immunization patch and method |
| 03/11/2009 | CN100467063C Immunological adjuvant, and its application in preparing vaccine and medicine for anti-virus |
| 03/11/2009 | CN100467062C Method of production of purified hepatitis A virus particles and vaccine preparation |
| 03/10/2009 | US7501553 Non-human transgenic mammal comprising a modified MSP-1 nucleic acid |
| 03/10/2009 | US7501501 MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
| 03/10/2009 | US7501498 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501496 Antibody binds OX40L, contains a Fc part derived from human origin; light chain and heavy chain variable domains defined by amino acid sequences and does not bind complement factor C1q; antiinflammatory, antiarthritic, antihistamine and bronchodilator agents; asthma treatment; gene expression |
| 03/10/2009 | US7501494 Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 03/10/2009 | US7501491 recombinant viral genome containing a deletion in the glycoprotein genes; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501395 Method of screening for antianxiety drugs |
| 03/10/2009 | US7501264 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 03/10/2009 | US7501247 Method of treating skin inflammation |
| 03/10/2009 | US7501234 Stress proteins and uses therefor |
| 03/10/2009 | US7501134 Biodegradable, formed without the use of surfactant; diagnosis, therapy vaccines, and/or in raising immune response; poly(D,L-lactide-co-glycolide) and antigens such as HIV antigens, meningitis B antigens, streptococcus antigens, hepatitis B virus antigens, hepatitis C virus antigens, pertussis antigens |
| 03/10/2009 | US7501132 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 03/10/2009 | US7501131 Haemophilus influenzae type IV pili |